| Ms Kim S Terhune, CNMW | |
|
4001 Fair Ridge Dr Ste 219, Fairfax, VA 22033-2917 | |
| (703) 273-9440 | |
| (703) 273-9445 |
| Full Name | Ms Kim S Terhune |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 4001 Fair Ridge Dr Ste 219, Fairfax, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821347287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 0024169584 (Virginia) | Primary |
| Entity Name | Dominion Women's Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932289592 PECOS PAC ID: 1456327824 Enrollment ID: O20040907001241 |
News Archive
The WaTER (Water Technologies for Emerging Regions) Center at the University of Oklahoma is bringing together researchers and advocates from around the world to focus on the life-sustaining resource, clean water.
Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before surgery, compared with placebo or no premedication, did not improve the self-reported patient experience the day after surgery, but was associated with longer time till removal off a breathing tube (extubation) and a lower rate of early cognitive recovery, according to a study in the March 3 issue of JAMA.
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc. has increased its on-going financial support of the company's research and development efforts by more than $2 million per year. The additional funding is expected to enhance NovaBay's pre-clinical and clinical development programs in the areas of eye, ear and sinus infections, as well as contact lens solutions.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers with the UCLA Department of Urology and UCLA's Jonsson Comprehensive Cancer Center.
› Verified 1 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
The WaTER (Water Technologies for Emerging Regions) Center at the University of Oklahoma is bringing together researchers and advocates from around the world to focus on the life-sustaining resource, clean water.
Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before surgery, compared with placebo or no premedication, did not improve the self-reported patient experience the day after surgery, but was associated with longer time till removal off a breathing tube (extubation) and a lower rate of early cognitive recovery, according to a study in the March 3 issue of JAMA.
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc. has increased its on-going financial support of the company's research and development efforts by more than $2 million per year. The additional funding is expected to enhance NovaBay's pre-clinical and clinical development programs in the areas of eye, ear and sinus infections, as well as contact lens solutions.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers with the UCLA Department of Urology and UCLA's Jonsson Comprehensive Cancer Center.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kim S Terhune, CNMW 4001 Fair Ridge Dr Ste 219, Fairfax, VA 22033-2917 Ph: (703) 273-9440 | Ms Kim S Terhune, CNMW 4001 Fair Ridge Dr Ste 219, Fairfax, VA 22033-2917 Ph: (703) 273-9440 |
News Archive
The WaTER (Water Technologies for Emerging Regions) Center at the University of Oklahoma is bringing together researchers and advocates from around the world to focus on the life-sustaining resource, clean water.
Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before surgery, compared with placebo or no premedication, did not improve the self-reported patient experience the day after surgery, but was associated with longer time till removal off a breathing tube (extubation) and a lower rate of early cognitive recovery, according to a study in the March 3 issue of JAMA.
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc. has increased its on-going financial support of the company's research and development efforts by more than $2 million per year. The additional funding is expected to enhance NovaBay's pre-clinical and clinical development programs in the areas of eye, ear and sinus infections, as well as contact lens solutions.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers with the UCLA Department of Urology and UCLA's Jonsson Comprehensive Cancer Center.
› Verified 1 days ago
Rebecca M Hindman, MSN CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-560-1611 | |
Ms. Susan M Mersch, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 10521 Rosehaven St Ste Ll100, Fairfax, VA 22030 Phone: 703-281-5000 Fax: 703-255-0765 | |
Dr. Carlyn Penwell, DNP, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd Ste 610, Fairfax, VA 22031 Phone: 703-698-2066 | |
Dr. Camilla Rose, DNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr Ste 203, Fairfax, VA 22033 Phone: 703-391-1500 | |
Melissa Suzanne Rogina, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3998 Fair Ridge Dr Ste 290, Fairfax, VA 22033 Phone: 033-595-5900 | |
Susan Lee Russo, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4001 Fair Ridge Dr, Suite 303, Fairfax, VA 22033 Phone: 703-359-4842 |